Advertisement

Henry Schein, Inc. HSIC

Set alert

Price alert · HSIC

All alert types
84.88 USD -1.56 -1.80%

At close · Oct 30

84.88 0.00 0.00%

After hours · Oct 30, 4:33 PM ET

Bid
84.86 × 2
Ask
84.89 × 2
84.49 Day range 86.95
62.90 52-week range 90.86
YTD
+12.30%
1 year
+34.94%
Open
86.57
Prev close
86.44
Mkt cap
9.67B
Vol
1.20M
Avg vol
1.16M
EPS
3.43
P/E
24.75
Div yield
0.00%
More statistics
Low
84.49
High
86.95
Forward P/E
14.17
Beta
0.84
Short ratio
6.93
Inst. own
111.18%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
86.60
200-d avg
81.02
1y target
96.87

2Y chart

Chart tools
Interval

Events in this range
  • Aug 5, 2025Earnings: 1.1; estimate 1.18; surprise -6.78%
  • Nov 4, 2025Earnings: 1.38; estimate 1.27; surprise 8.66%
  • Feb 24, 2026Earnings: 1.34; estimate 1.3; surprise 3.08%
  • May 5, 2026Earnings: 1.32; estimate 1.2; surprise 10%
  • Aug 4, 2026Earnings: 1.27; estimate 1.24; surprise 2.42%
  • Aug 5, 2026Rating: BTIG · Buy → Buy
  • Aug 5, 2026Rating: Citigroup · Buy → Buy
  • Aug 5, 2026Rating: UBS · Neutral → Neutral
  • Aug 6, 2026Rating: Barclays · Overweight → Overweight
  • Aug 19, 2026Rating: BTIG · Buy → Buy
  • Oct 14, 2026Rating: Leerink Partners · Market Perform → Market Perform
Signals (72)
NameDateAgo
MACD: Buy SignalOct 13, 20262 weeks ago
SMA: BearishSep 15, 20261 month ago
SMA: BullishSep 11, 20261 month ago
SMA: BearishSep 10, 20261 month ago
MACD: Sell SignalAug 19, 20262 months ago
MACD: Buy SignalAug 5, 20262 months ago
MACD: Sell SignalJul 20, 20263 months ago
MACD: Buy SignalJul 16, 20263 months ago
MACD: Sell SignalJul 9, 20263 months ago
RSI: OverboughtJul 2, 20264 months ago
RSI: OverboughtJun 25, 20264 months ago
RSI: OverboughtJun 12, 20264 months ago
RSI: OverboughtJun 9, 20264 months ago
SMA: BullishMay 27, 20265 months ago
MACD: Buy SignalMay 19, 20265 months ago
SMA: BullishMay 14, 20265 months ago
SMA: BearishMay 6, 20265 months ago
SMA: BullishMay 5, 20265 months ago
SMA: BearishMay 4, 20266 months ago
MACD: Sell SignalApr 29, 20266 months ago
SMA: BearishApr 28, 20266 months ago
SMA: BullishApr 14, 20266 months ago
MACD: Buy SignalApr 2, 20267 months ago
SMA: BullishMar 30, 20267 months ago
SMA: BearishMar 27, 20267 months ago
SMA: BearishMar 6, 20267 months ago
MACD: Sell SignalMar 5, 20268 months ago
SMA: BullishFeb 20, 20268 months ago
MACD: Buy SignalFeb 20, 20268 months ago
SMA: BearishFeb 19, 20268 months ago
MACD: Sell SignalFeb 19, 20268 months ago
MACD: Buy SignalFeb 6, 20268 months ago
SMA: BullishFeb 5, 20268 months ago
SMA: BearishJan 28, 20269 months ago
MACD: Sell SignalJan 9, 20269 months ago
MACD: Buy SignalJan 8, 20269 months ago
MACD: Sell SignalDec 23, 202510 months ago
MACD: Buy SignalDec 11, 202510 months ago
MACD: Sell SignalDec 2, 202511 months ago
RSI: OverboughtNov 25, 202511 months ago
RSI: OverboughtNov 13, 202511 months ago
RSI: OverboughtNov 10, 202511 months ago
SMA: BullishNov 4, 202512 months ago
SMA: BullishNov 4, 202512 months ago
RSI: OverboughtNov 4, 202512 months ago
MACD: Buy SignalOct 22, 20251 year ago
MACD: Sell SignalSep 25, 20251 year ago
SMA: BearishSep 24, 20251 year ago
SMA: BullishSep 23, 20251 year ago
MACD: Buy SignalSep 23, 20251 year ago
MACD: Sell SignalSep 22, 20251 year ago
SMA: BearishSep 12, 20251 year ago
SMA: BullishSep 11, 20251 year ago
MACD: Buy SignalSep 11, 20251 year ago
MACD: Sell SignalSep 10, 20251 year ago
MACD: Buy SignalAug 14, 20251 year ago
SMA: BearishJul 25, 20251 year ago
SMA: BullishJul 22, 20251 year ago
SMA: BearishJul 14, 20251 year ago
MACD: Sell SignalJul 11, 20251 year ago
MACD: Buy SignalJun 24, 20251 year ago
MACD: Sell SignalMay 30, 20251 year ago
SMA: BullishMay 8, 20251 year ago
MACD: Buy SignalApr 22, 20251 year ago
RSI: OversoldApr 7, 20251 year ago
SMA: BearishMar 11, 20251 year ago
SMA: BullishMar 7, 20251 year ago
SMA: BearishFeb 26, 20251 year ago
MACD: Sell SignalFeb 11, 20251 year ago
RSI: OverboughtJan 29, 20251 year ago
SMA: BullishJan 17, 20251 year ago
MACD: Buy SignalJan 14, 20251 year ago

Key statistics

Market cap
9.67B
Enterprise value
14.86B
Trailing P/E
24.75
Forward P/E
14.17
PEG ratio
1.72
Price / sales
0.71
Price / book
3.01
EPS (TTM)
3.43
Beta
0.84
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
2.96%
Revenue (TTM)
13.60B
Revenue growth
6.70%
Free cash flow
446.00M
Total cash
157.00M
Total debt
3.81B
Return on equity
8.85%
Shares outstanding
113.92M
Short % of float
9.79%
50-day average
86.60
200-day average
81.02

Analyst view

Consensus: buy

Buy
Price target (mean) 96.87 +14.1% upside
Target (low)
64.00
Target (mean)
96.87
Target (high)
110.00
Ratings (0m) 16 8 buy · 7 hold · 1 sell
  • Strong buy4
  • Buy4
  • Hold7
  • Sell1
  • Strong sell0

Next earnings

Nov 3, 2026

Expected Nov 3, 2026. Consensus EPS estimate 1.36.

Earnings history

Financials — quick view

All financials
HSIC Revenue — quarterly 3.46B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
HSIC Net income — quarterly 94.00M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
HSIC EPS — quarterly 0.83
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

HSIC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 3, 2026Sep 27, 20261.36———
Aug 4, 2026Jun 27, 20261.241.27+0.03+2.42%
May 5, 2026Mar 28, 20261.201.32+0.12+10.00%
Feb 24, 2026Dec 27, 20251.301.34+0.04+3.08%
Nov 4, 2025Sep 27, 20251.271.38+0.11+8.66%
Aug 5, 2025Jun 28, 20251.181.10-0.08-6.78%

Upgrades / downgrades

HSIC analyst upgrades and downgrades
DateFirmActionFromTo
Oct 14, 2026Leerink PartnersmainMarket PerformMarket Perform
Aug 19, 2026BTIGmainBuyBuy
Aug 6, 2026BarclaysmainOverweightOverweight
Aug 5, 2026UBSmainNeutralNeutral
Aug 5, 2026CitigroupmainBuyBuy
Aug 5, 2026BTIGreitBuyBuy

About Henry Schein, Inc.

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Sector
Healthcare
Industry
Medical Distribution
Country
United States

News

Your note

Sign in to keep a note on HSIC — it syncs with the Stock Master app.

Insider holders

HSIC insider holders
InsiderRelationLatest transactionDateShares held
ALBERTINI ANDREAOfficerStock Award(Grant)Mar 5, 2026122,092
BERGMAN STANLEY MDirectorStock GiftMay 25, 2026643,124
BRESLAWSKI JAMES PPresidentStock Award(Grant)Mar 9, 2025206,542
CONNETT BRADFORD COfficerSaleMar 18, 202562,688
ETTINGER MICHAEL S.Chief Operating OfficerStock GiftMar 16, 2026112,418
LOWERY FREDERICK M.Chief Executive OfficerStock Award(Grant)Mar 5, 202695,156

Institution ownership

HSIC institution ownership
Holder% heldSharesValueReported
Kohlberg Kravis Roberts & Co. L.P.14.04%15,652,0321.33BJun 29, 2026
FMR, LLC6.78%7,553,901641.18MJun 29, 2026
Blackrock Inc.6.30%7,024,663596.25MJun 29, 2026
Artisan Partners Limited Partnership5.80%6,467,467548.96MJun 29, 2026
Vanguard Capital Management LLC5.69%6,346,669538.71MJun 29, 2026
JPMORGAN CHASE & CO3.90%4,342,929368.63MJun 29, 2026

Fund ownership

HSIC fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.77%3,088,611262.16MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.25%2,507,310212.82MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.00%2,231,443189.40MJun 29, 2026
Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF2.00%2,223,555188.74MSep 29, 2026
Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund1.94%2,164,774183.75MJul 30, 2026
J.P. Morgan Fleming Mutual Fd. Group, Inc.-JPMorgan Mid Cap Value Fd.1.44%1,606,529136.36MJun 29, 2026
Advertisement